Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices
NCT ID: NCT05124405
Last Updated: 2025-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
35 participants
INTERVENTIONAL
2018-05-24
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To evaluate the feasibility of a CGM-based physical activity intervention that includes the use of CGM and Fitbit®.
Secondary objectives:
To examine changes in physical activity motivation and other related psychosocial variables (e.g., intention, perceived benefits, outcome expectancy) before and after the intervention.
Exploratory objective:
Examine cancer-related biomarkers and their associations with daily glucose pattern.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heart Rate Tracker (Fitbit)
continuous heart rate activity
Fitbit
wearable activity tracker
Continuous Glucose Monitor
wearable activity tracker
Continuous Glucose Monitor (CGM)
monitoring daily exercise-related activities
Fitbit
wearable activity tracker
Continuous Glucose Monitor
wearable activity tracker
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fitbit
wearable activity tracker
Continuous Glucose Monitor
wearable activity tracker
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index (BMI) 25 kg/m2
* Engage in less than 150 minutes of moderate-intensity PA per week in the past month
* Capable of participating in moderate-vigorous unsupervised exercise (as determined by the Physical Activity Readiness Questionnaire (PARQ) or a medical release from their physician)
* Self-reported ability to walk one block without pain or discomfort
* Have a smart phone with daily internet access that is compatible with the LibreLink app
* Ability to speak, read, and write in English
* For the cancer survivor cohort (participant accession number #21 and beyond), individuals must have been diagnosed with stage I-III breast or colorectal cancer and completed adjuvant therapy (i.e., chemo and/or radiation therapy).
Exclusion Criteria
* Self-reported use of oral antidiabetic agents (OADs)
* Previous or current treatment with any insulin regimen other than basal insulin, e.g. prandial or pre-mixed insulin (short term treatment due to intercurrent illness including gestational is allowed at the discretion for the investigator)
* Current use of a continuous glucose monitor
* Fasting glucose \> 125 mg/dL
* Pregnancy
* Self-reported health issues that limit physical activity
* On dialysis
* Work overnight shifts
* Unwilling to use CGM
* Current participation in other wellness or weight loss-related program or intervention
* Currently on a low-carb diet
* Unable to receive REDCap survey through their mobile phones
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen Basen-Engquist, MD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Liao Y, Brannon GE, Rethorst CD, Baum M, Bevers TB, Schembre SM, Basen-Engquist KM. Using Continuous Glucose Monitoring as a Biological Feedback Strategy to Motivate Physical Activity in Cancer Survivors: A Mixed-Methods Pilot Study. Cancer Control. 2025 Jan-Dec;32:10732748251359406. doi: 10.1177/10732748251359406. Epub 2025 Jul 28.
Related Links
Access external resources that provide additional context or updates about the study.
M D Anderson Cancer Center website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2019-02652
Identifier Type: OTHER
Identifier Source: secondary_id
2018-0299
Identifier Type: -
Identifier Source: org_study_id